---
title: "Taconic Newsletter: Transportation Affects Gut Microbiome of Laboratory MiceNew Insights on Emerging Science and Technologies"
---

 Experts at Taconic Biosciences discuss the significance of the difference between C57BL/6J and C57BL/6N substrains, how to choose proper...>Scientific News & Insights Designed To Help Take Your Research Further

| Not rendering correctly? View this email as a web page here. August 2019 INSIGHT Methods of Animal Model Identification Choosing the right animal identification method is critical. Loss of identification can render the animal, and the data it would provide, unusable. If the animal becomes unusable, the study will have to be repeated. Proper, secure animal identification is therefore both necessary for good science and part of our ethical imperative to reduce the number of animals we use. READ MORE → INSIGHT Transportation Affects Gut Microbiome of Laboratory Mice Experimental controls are at the center of every quality experiment, and understanding the causes of microbiome variability is key to controlling for microbiome-related effects. Researchers that utilize murine models attempt to control for possible microbiome variability by ordering mice from the same vendor... READ MORE → VIDEO Genetic Background in Syngeneic Models Through this excerpt from Taconic Biosciences' Webinar, "Advanced Toolkit For Syngeneic Tumor Modeling in Mice," Dr. Philip Dubé considers the role of genetic background when identifying the proper syngeneic model as well as the importance of validating substrain and specific cell line. Syngeneic models depend on the implanted tumor cell not being rejected by the immune system WATCH NOW → ON-DEMAND WEBINAR Improving Preclinical Neuroscience Study Design with AlzPED Data In this webinar, we join Dr. Lorenzo Refolo, Director for Alzheimer’s Disease Drug Discovery and Development at the National Institute on Aging (NIA), to learn how AlzPED can promote the reproducibility and translatability of neuroscience research. Tune in to: Identify elements of rigorous study design and requirements for transparent reporting. Learn how to mine AlzPED for data on preclinical efficacy studies of your disease of interest. WATCH NOW → |
| --- |

| Taconic Biosciences Inc.   1 Discovery Drive, Suite 304    Rensselaer,  NY   12144   USA You received this email because you are subscribed to Taconic Biosciences Insights from Taconic Biosciences Inc.. Update your email preferences to choose the types of emails you receive.  Unsubscribe from all future emails  |
| --- |
|  |